MediciNova Inc. is a biopharmaceutical company founded on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet need with a commercial focus on the U.S. market. MediciNova's current strategy is to focus on its two prioritized product candidates, MN-166 for neurological disorders, and MN-221 for the treatment of acute exacerbations of asthma. MediciNova is engaged in strategic partnering and consortium funding discussions to support further development of both the MN-221 and ibudilast/MN-166 programs.
Company Website: http://www.medicinova.com/
MediciNova Inc. (NASDAQ: MNOV) Stock Message Board
38273 | Sponsor | 03/28/2024 2:41:26 PM | |
10 | MNOV Stock year to date has changed +70.09% | Jake13 | 12/02/2014 2:11:52 AM |
9 | MNOV 3.64 Medicinova Stock Charts $MNOV Last | chartguy89 | 12/02/2014 2:00:37 AM |
8 | $MNOV recovery gap & candle | PoemStone | 12/01/2014 5:14:29 PM |
7 | $MNOV still climbin | PoemStone | 10/15/2014 11:21:03 AM |
6 | As seen on Low Floats Up 50% | PoemStone | 09/15/2014 6:31:30 PM |
5 | $MNOV bre | PoemStone | 09/02/2014 6:33:49 PM |
4 | Latest Medicinova (MNOV) Headlines Canadian Forex | Stock_Tracker | 03/13/2014 11:13:34 AM |
3 | MNOV Stock Charts Last: +0.05 Saturday, March 1, | chartguy89 | 03/01/2014 7:55:13 PM |
2 | MNOV Stock Charts Last: -0.06 Friday, February | chartguy89 | 02/28/2014 1:20:20 AM |
1 | Amira Nature Foods Ltd. (NYSE:ANFI) ANFI reported | karnacua2 | 11/12/2013 1:21:30 AM |